AGIO vs JLL · rev $65.5M vs P/E 23, rev $13.31B
Agios Pharm (AGIO) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
AGIO currently screens at market cap $1.68B. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the AGIO and JLL stock pages for the full models.
Not investment advice.